Since the discovery in Scotland of a population of wild rats resistant to anticoagulant rodenticides (Boyle, 1960) , others were reported from several European countries (Greaves, 1970) and the United States (Jackson & Kaukeinen, 1972) . The resistance gene from wild warfarin-resistant rats trapped in Wales has been introduced into Wistarderived rats in England to give the HW strain (Greaves & Ayres, 1967) and into Sprague Dawley-derived rats in the United States (Pool et al., 1968) . It was shown in America by Hermodson et al. (1969) , that these resistant rats did not differ from susceptible Holtzmann rats in their ability to metabolize and excrete warfarin, but they did possess an increased requirement for dietary vitamin K1, possibly owing to the presence of an altered protein receptor with a lowered binding affinity for both vitamin K1 and warfarin. A similar situation seemed to occur in HW rats (Martin, 1973; Townsend et d., 1975) . In warfarin-treated susceptible rats, vitamin K, 2,3-epoxide accumulated in the liver (Bell et al., 1972) as the enzyme system reducing it to vitamin K1 was inhibited by warfarin in uiuo (Bell & Matschiner, 1970) . However, Sprague-Dawley-derived resistant animals did not show this increase, but the study suggested that the altered enzyme was less effective in catalysing the vitamin K1 epoxide reduction (Bell & Caldwell, 1973) , and this was confirmed by studies in uirro Zimmermann & Matschiner, 1974) . They showed that the liver enzyme system was located in the liver microsomal fraction and required either the lOOOOg precipitate or a thiol-group reagent as a source of reducing equivalents. These workers used 3H-labelled vitamin K1 epoxide and separated thevitamin K, produced by reverse-phase t.1.c. This is not a readily available assay, and we have evaluated an alternative method for use in screening animals for resistance and the assessment of new rodenticides.
Male Wistar rats (200-25Og) were killed by cervical dislocation and their livers macerated in 0.25~-sucrose/0.025~-potassium phosphate buffer (pH7.4)/5.0m~-dithiothreitol to give a 10% (w/v) homogenate. Cell fractions were obtained by centrifugation
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BIOCHEMICAL SOCIETY TRANSACTIONS (Bunyan etal., 1972) . Vitamin K1 epoxidewaspreparedfromvitaminK1 bythemethodof Tishler et al. (1 940) . The enzyme assays were carried out in 25 ml flasks open to the air and shaken in a water bath at 37°C. The postmitochondrial supernatant (2ml) was preincubated with the homogenizing buffer (1 ml) or buffer containing warfarin sodium, for 5min and the reaction started by adding vitamin K1 epoxide in 5 0~1 of ethanol. After 20min the contents of each flask were added to 7ml of propan-Zol/hexane (3: 2, v/v) and 1 g of NaCl in an ice-cold stoppered glass centrifuge tube and mixed with a vortex mixer. The two phases were separated by centrifuging at 2000g for 15min. The upper phase was removed, dried by passing it down a short column of anhydrous Na2S0, and collected in a glass vial. The lower phase was extracted with two 5ml volumes ofhexane and the upper phases were treated as previously. Thecombined extract was concentrated by evaporation under N2 and quantitatively transferred to a tapered stoppered tube. The extract was evaporated just to dryness, immediately redissolved in loop1 of chloroform and sealed until analysed. All the procedures after the preincubation were carried out in a darkened room. Vitamin K1 and its epoxide were separated by high-performance liquid chromatography (LC 750, ARL, Luton, U.K.) by using a 50cm Permaphase ODS column and methanol/water (90: 10, v/v) at a constant pressure of I.03MPa. The U.V. detector (254 nm) gave a response that was linear over the range 50-500ng of vitamin K1 and 2-16pg of vitamin K1 epoxide when standard solutions were analysed separately or as mixtures.
The recovery of vitamin K1 and its epoxide from assay mixtures where the enzyme preparation was added after the addition of the extracting solvent were reproducible, and not less than 80 %. The trace of a typical assay is shown in Fig. 1 .
The assay was found to be linear over the range 50-2OOmg fresh weight of liver, and 540min. A comparison of the effect of substrate concentration on the activity of extracts prepared from Wistar susceptible (TAS) and resistant (HW) rats showed that the control value for the TAS-strain rats was 250nmoI of vitamin K1 formed/h per g of liver and that for the HW strain was 40% lower (Fig. 2) . In the presence of 3p~-warfarin sodium, both strains had the same activity, approx. 75nmol of vitamin
